Cargando…
A Toll-like Receptor-Activating, Self-Adjuvant Glycan Nanocarrier
The global pandemic of COVID-19 highlights the importance of vaccination, which remains the most efficient measure against many diseases. Despite the progress in vaccine design, concerns with suboptimal antigen immunogenicity and delivery efficiency prevail. Self-adjuvant carriers–vehicles that can...
Autores principales: | Xie, Daping, Niu, Yiming, Mu, Ruoyu, Campos de Souza, Senio, Yin, Xiaoyu, Dong, Lei, Wang, Chunming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110926/ https://www.ncbi.nlm.nih.gov/pubmed/35592309 http://dx.doi.org/10.3389/fchem.2022.864206 |
Ejemplares similares
-
A pocket-escaping design to prevent the common interference with near-infrared fluorescent probes in vivo
por: Xing, Panfei, et al.
Publicado: (2020) -
Differential Foreign Body Reactions between Branched and Linear Glucomannan Scaffolds
por: Li, Yuwei, et al.
Publicado: (2022) -
A toll-like receptor agonist mimicking microbial signal to generate tumor-suppressive macrophages
por: Feng, Yanxian, et al.
Publicado: (2019) -
Precise immunological evaluation rationalizes the design of a self-adjuvanting vaccine composed of glycan antigen, TLR1/2 ligand, and T-helper cell epitope
por: Chang, Tsung-Che, et al.
Publicado: (2022) -
Chitosan-based self-assembled nanocarriers coordinated to cisplatin for cancer treatment
por: Trummer, Ronny, et al.
Publicado: (2018)